about
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. ...
Read More
0.71
-0.01
(-1.39%)
82,430
XNAS Volume
XNAS 14 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
MetaVia Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..